[Table/Fig-4]:
Clinical characteristics of patients with Anisomyopia
| S. No. | Age/Sex | Amblyopic Eye | Fellow Eye | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BCVA Pre therapy | Log Mar Units | Prescription (SE)* | BCVA Post therapy | BCVA Pre therapy | Log Mar Units | Prescription (SE)* | BCVA Post therapy | ||
| 1. | 22year/F | 20/125 | 0.8 | -4DS | 20/25 | 20/20 | 00 | -1DS | 20/20 |
| 2. | 12year/M | 20/125 | 0.8 | -3.50DS | 20/20 | 20/20 | 00 | - | 20/20 |
| 3. | 19year/F | 20/63 | 0.5 | -3.25DS | 20/20 | 20/20 | 00 | -1.0DS | 20/20 |
| 4. | 12year/M | 20/125 | 0.8 | -4DS | 20/25 | 20/20 | 00 | - | 20/20 |
| 5. | 12year/M | 20/80 | 0.6 | -3DS | 20/20 | 20/20 | 00 | -0.75DS | 20/20 |
| 6. | 17year/F | 20/200 | 1.0 | -5.25DS | 20/25 | 20/20 | 00 | - | 20/20 |
| 7. | 15year/F | 20/63 | 0.5 | -3.50DS | 20/20 | 20/20 | 00 | -0.5DS | 20/20 |
| 8. | 12year/F | 20/125 | 0.8 | -3.50DS | 20/20 | 20/20 | 00 | -1.00DS | 20/20 |
| 9. | 19year/M | 20/200 | 1.0 | -5DS | 20/20 | 20/20 | 00 | -0.75DS | 20/20 |
| 10. | 16year/F | 20/200 | 1.0 | -6.25DS | 20/25 | 20/20 | 00 | -0.50DS | 20/20 |
| 11. | 13year/M | 20/80 | 0.6 | -3.25DS | 20/20 | 20/20 | 00 | -1.75DS | 20/20 |
| 12. | 28year/F# | 20/200 | 1.0 | -6.25DS | 20/80 | 20/20 | 00 | -1.50DS | 20/20 |
| 13. | 20year/F | 20/80 | 0.6 | -4.50DS | 20/20 | 20/25 | 0.1 | -1.25DS | 20/20 |
| 14. | 14year/M | 20/80 | 0.6 | -3.25DS | 20/20 | 20/20 | 00 | -1.50DS | 20/20 |
| 15. | 16year/F | 20/125 | 0.8 | -4.50DS | 20/20 | 20/20 | 00 | - | 20/20 |
| 16. | 20year/M | 20/400 | 02 | -6.25DS | 20/25 | 20/20 | 00 | -1DS | 20/20 |
| 17. | 30year/# | 20/400 | 02 | -9.50DS | 20/80 | 20/63 | 0.5 | -7.50DS | 20/25 |
* Spherical equivalent, # did not fulfill our criteria of successful treatment